Novel drug targets for asthma and COPD: lessons learned from in vitro and in vivo models

Katie E Baker,Sara J Bonvini,Chantal Donovan,Rachel E Foong,Bing Han,Aruni Jha,Yasin Shaifta,Marieke Smit,Jill R Johnson,Lyn M Moir

DOI: https://doi.org/10.1016/j.pupt.2014.05.008

Abstract:Asthma and chronic obstructive pulmonary disease (COPD) are highly prevalent respiratory diseases characterized by airway inflammation, airway obstruction and airway hyperresponsiveness. Whilst current therapies, such as β-agonists and glucocorticoids, may be effective at reducing symptoms, they do not reduce disease progression. Thus, there is a need to identify new therapeutic targets. In this review, we summarize the potential of novel targets or tools, including anti-inflammatories, phosphodiesterase inhibitors, kinase inhibitors, transient receptor potential channels, vitamin D and protease inhibitors, for the treatment of asthma and COPD.